Bath & Body Works (NYSE:BBWI) Upgraded by BMO Capital Markets to “Hold” Rating

Posted by Geri Gentry on Sep 11th, 2026

Bath & Body Works (NYSE:BBWI – Get Free Report) was upgraded by BMO Capital Markets to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks reports.

BBWI has been the topic of several other research reports. Barclays dropped their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 27th. Telsey Advisory Group lowered their target price on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research note on Thursday, May 28th. Wells Fargo & Company dropped their target price on Bath & Body Works from $26.00 to $24.00 and set an “overweight” rating on the stock in a research report on Thursday, August 27th. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Finally, Robert W. Baird reduced their price target on Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a report on Thursday, August 27th. Four equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $22.13.

View Our Latest Research Report on BBWI

Bath & Body Works Stock Down 1.5%

NYSE BBWI opened at $17.45 on Tuesday. The stock has a market cap of $3.52 billion, a PE ratio of 4.54, a P/E/G ratio of 1.82 and a beta of 1.38. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $28.26. The business has a 50 day moving average price of $19.71 and a two-hundred day moving average price of $19.63.

Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.38. The company had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. Bath & Body Works’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter last year, the company earned $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Sell-side analysts anticipate that Bath & Body Works will post 2.73 EPS for the current fiscal year.

Institutional Trading of Bath & Body Works

Hedge funds and other institutional investors have recently bought and sold shares of the company. Parallel Advisors LLC lifted its stake in Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after purchasing an additional 567 shares during the last quarter. State of Michigan Retirement System raised its holdings in shares of Bath & Body Works by 1.2% during the first quarter. State of Michigan Retirement System now owns 49,300 shares of the company’s stock worth $920,000 after purchasing an additional 600 shares during the period. Meeder Asset Management Inc. raised its holdings in shares of Bath & Body Works by 28.5% during the fourth quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after purchasing an additional 637 shares during the period. State of Wyoming lifted its position in shares of Bath & Body Works by 6.2% in the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after buying an additional 661 shares during the last quarter. Finally, Vident Advisory LLC boosted its holdings in shares of Bath & Body Works by 2.8% in the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock valued at $756,000 after buying an additional 692 shares during the period. 95.14% of the stock is owned by institutional investors.

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.